Combating the eosinophil with anti-interleukin-5 therapy.
Wechsler
Michael E
ME
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy*; D015848:Interleukin-5 / Q000276:immunology*; D011241:Prednisone / Q000008:administration & dosage
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; D015848:Interleukin-5; C434107:mepolizumab; D011241:Prednisone